KFAS
ETON icon

Keating Financial Advisory Services’s Eton Pharmaceutcials ETON Stock Holding History

Keating Financial Advisory Services’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23K Buy
34
+33
+3,300% +$968 ﹤0.01% 2108
2026
Q1 		$25 Buy
+1
New +$17 ﹤0.01% 2492

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Keating Financial Advisory Services's ETON Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Eton Pharmaceutcials (ETON) stake by 3,300% in Q2 2026, buying an estimated $968 and bringing the position to 34 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Keating Financial Advisory Services first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Keating Financial Advisory Services held 34 shares of Eton Pharmaceutcials worth $1.23K as of Q2 2026.
  • Keating Financial Advisory Services bought 33 Eton Pharmaceutcials shares in Q2 2026, an estimated $968.
  • Eton Pharmaceutcials made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2108 holding.
  • Keating Financial Advisory Services first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.